Jove
Visualize
Contact Us

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

889
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
889
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Immunomethylomic Profiles Of Long-term Head And Neck Squamous Cell Carcinoma Survivors On Immune Checkpoint Inhibitors.
  1. Home
  3. Immunomethylomic Profiles Of Long-term Head And Neck Squamous Cell Carcinoma Survivors On Immune Checkpoint Inhibitors.

Related Experiment Video

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

322

Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint

Min Kyung Lee1, Ze Zhang1, Kartik Sehgal2

  • 1Department of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH  03755, USA.

Epigenomics
|June 13, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Predicting immunotherapy response in head and neck squamous cell carcinoma (HNSCC) is challenging. Monitoring immune cell fluctuations, like CD8 T cells, may reveal biomarkers for treatment success in HNSCC patients.

Keywords:
DNA methylationhead and neck squamous cell carcinomaimmune checkpoint inhibitorsimmune profilesimmunomethylomicsmethylation cytometry

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.5K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K

Related Experiment Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

322
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.5K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • Predicting immunotherapy response in head and neck squamous cell carcinoma (HNSCC) remains a significant clinical challenge.
  • Identifying reliable biomarkers is crucial for optimizing treatment strategies and patient outcomes.

Purpose of the Study:

  • To investigate the dynamic changes in immune cell profiles of HNSCC patients undergoing immunotherapy.
  • To explore potential immune-based biomarkers for predicting treatment response in HNSCC.

Main Methods:

  • DNA methylation cytometry was employed to analyze immune cell populations.
  • Longitudinal immune profiling was conducted on six HNSCC patients with a positive immunotherapy response over one year.

Main Results:

  • An initial surge in CD8 T memory cells and natural killer cells was observed during the first four immunotherapy cycles, returning to baseline after one year.
  • HNSCC immunotherapy responders exhibited lower baseline CD8 T cell levels, which normalized post-treatment compared to healthy controls.

Conclusions:

  • Dynamic monitoring of immune cell fluctuations, particularly CD8 T cells, may serve as a potential biomarker for immunotherapy response in HNSCC.
  • These findings highlight the utility of immune profiling in understanding and predicting treatment efficacy in HNSCC.